Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Depression

Recruiting

Registered drugNo placebo

Safety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol

Contact Research Centre

Depression+1

Recruiting

InvestigationalNo placebo

Efficacy of high- and low-dose psilocybin in preventing relapse in adults with severe alcohol use disorder and depressive symptoms after detoxification

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Psilocybine

Contact Research Centre

Depression

Recruiting

Registered drugNo placebo

Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Agomelatine

Contact Research Centre

Depression

Recruiting

Registered drug

Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Lactose Monohydrate

Contact Research Centre

Depression

Recruiting

Investigational

Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

Investigational

Italy

Participants:18–64 years
Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol

Contact Research Centre

Depression

Recruiting

Registered drugNo placebo

Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years

Contact Research Centre

Depression

Recruiting

Registered drug

Study on Psilocybin and Trazodone for Adults with Treatment-Resistant Depression

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol

Contact Research Centre

Depression+1

Recruiting

Registered drug

Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia

Registered drug

France

Participants:18–64 years
Substances:Melatonin

Contact Research Centre

Depression+2

Recruiting

Registered drug

Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

Registered drug

Denmark

Participants:18–64 years
Substances:Semaglutide

Contact Research Centre

Depression

Recruiting

InvestigationalNo placebo

Study on Brain Activity in Treatment-Resistant Depression Using [18F]MC225 for Patients with Depression

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:[18F]Mc225

Contact Research Centre

Depression

Recruiting

Registered drug

Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Depression

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Choline Alfoscerate for Treating Mild Depression in Elderly Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:CHOLINE ALFOSCERATE

Contact Research Centre

Find therapies in clinical trials near you

35 trials match your criteria

Depression

Safety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression

Depression+1

Efficacy of high- and low-dose psilocybin in preventing relapse in adults with severe alcohol use disorder and depressive symptoms after detoxification

Depression

Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

Depression

Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

Depression

Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

Depression

Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

Depression

Study on Psilocybin and Trazodone for Adults with Treatment-Resistant Depression

Depression+1

Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia

Depression+2

Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

Depression

Study on Brain Activity in Treatment-Resistant Depression Using [18F]MC225 for Patients with Depression

Depression

Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

Depression

Study on the Effectiveness of Choline Alfoscerate for Treating Mild Depression in Elderly Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.